Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer combined with moderate-to-severe pulmonary dysfunction

MWA represents a safe, effective, and potential alternative therapeutic option for patients with stage I NSCLC and moderate-to-severe pulmonary dysfunction.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-01-23
DOI
https://doi.org/10.3389/fonc.2026.1750853
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer combined with moderate-to-severe pulmonary dysfunction

Fanlei Kong, Yuxian Chen, Chengcheng Du, Hong Meng et al.
Frontiers in Oncology
Lung Cancer Diagnosis and Treatment
article

Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer combined with moderate-to-severe pulmonary dysfunction

Fanlei Kong, Yuxian Chen, Chengcheng Du, Hong Meng, Chunhai Li
article en

Abstract

MWA represents a safe, effective, and potential alternative therapeutic option for patients with stage I NSCLC and moderate-to-severe pulmonary dysfunction.

Frontiers in OncologyVol. 16
Qilu Hospital of Shandong University (CN)
Good health and well-being
Openalex Percentile: Top 81%
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer combined with moderate-to-severe pulmonary dysfunction — Fanlei Kong, Yuxian Chen, et al. · Frontiers in Oncology (2026) | TGRS Research Map | TGRS